Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders
Brain · 03.06.2024 · 147 (6) · 2085-2097
DOI: 10.1093/brain/awae055 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Brain, online erschienen am 13.05.2024. Verfasst von James Liu und 44 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Phenotype. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Save sight society NZ, Retina NZ, and the Ombler trust, UCL Institute of Ophthalmology, Research to Prevent Blindness.
Abstract (Originalsprache)
Biallelic pathogenic variants in the PNPLA6 gene cause a broad spectrum of disorders leading to gait disturbance, visual impairment, anterior hypopituitarism and hair anomalies. PNPLA6 encodes neuropathy target esterase (NTE), yet the role of NTE dysfunction on affected tissues in the large spectrum of associated disease remains unclear. We present a systematic evidence-based review of a novel cohort of 23 new patients along with 95 reported individuals with PNPLA6 variants that implicate missense variants as a driver of disease pathogenesis. Measuring esterase activity of 46 disease-associated and 20 common variants observed across PNPLA6-associated clinical diagnoses unambiguously reclassified 36 variants as pathogenic and 10 variants as likely pathogenic, establishing a robust functional assay for classifying PNPLA6 variants of unknown significance. Estimating the overall NTE activity of affected individuals revealed a striking inverse relationship between NTE activity and the presence of retinopathy and endocrinopathy. This phenomenon was recaptured in vivo in an allelic mouse series, where a similar NTE threshold for retinopathy exists. Thus, PNPLA6 disorders, previously considered allelic, are a continuous spectrum of pleiotropic phenotypes defined by an NTE genotype:activity:phenotype relationship. This relationship, and the generation of a preclinical animal model, pave the way for therapeutic trials, using NTE as a biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Fermentation Facility, Biochemistry and Biophysics Center, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA.
- Visual Function Core, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Genetic Engineering Core, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI 48105, USA.
- Department of Human Genetics, University of Michigan, Ann Arbor, MI 48105, USA.
ORCID-Profile: Haohua Qian, Craig Blackstone, Matthis Synofzik
Förderung
- Save sight society NZ, Retina NZ, and the Ombler trust
- UCL Institute of Ophthalmology
- Research to Prevent Blindness
- Moorfields Eye Hospital
- NEI NIH HHS
- Fight for Sight UK
- National Institute of Health Research Biomedical Research Centre
- Great Ormond Street Hospital Institute for Child Health
Zitieren
APA
Liu, J., He, Y., Lwin, C., Han, M., Guan, B., Naik, A., Bender, C., Moore, N., Huryn, L. A., Sergeev, Y. V., Qian, H., Zeng, Y., Dong, L., Liu, P., Lei, J., Haugen, C. J., Prasov, L., Shi, R., Dollfus, H., …, & Hufnagel, R. B. (2024). Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders. Brain, 147(6), 2085-2097. https://doi.org/10.1093/brain/awae055
Vancouver
Liu J, He Y, Lwin C, Han M, Guan B, Naik A, et al. Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders. Brain. 2024;147(6):2085-2097. doi:10.1093/brain/awae055
BibTeX
@article{Liu2024,
author = {Liu, James and He, Yi and Lwin, Cara and Han, Marina and Guan, Bin and Naik, Amelia and Bender, Chelsea and Moore, Nia and Huryn, Laryssa A and Sergeev, Yuri V and Qian, Haohua and Zeng, Yong and Dong, Lijin and Liu, Pinghu and Lei, Jingqi and Haugen, Carl J and Prasov, Lev and Shi, Ruifang and Dollfus, Hélène and Aristodemou, Petros and Laich, Yannik and Németh, Andrea H and Taylor, John and Downes, Susan and Krawczynski, Maciej R and Meunier, Isabelle and Strassberg, Melissa and Tenney, Jessica and Gao, Josephine and Shear, Matthew A and Moore, Anthony T and Duncan, Jacque L and Menendez, Beatriz and Hull, Sarah and Vincent, Andrea L and Siskind, Carly E and Traboulsi, Elias I and Blackstone, Craig and Sisk, Robert A and Miraldi Utz, Virginia and Webster, Andrew R and Michaelides, Michel and Arno, Gavin and Synofzik, Matthis and Hufnagel, Robert B},
title = {Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders},
journal = {Brain},
year = {2024},
volume = {147},
number = {6},
pages = {2085--2097},
doi = {10.1093/brain/awae055}
}
EUVIMED